# E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

> **NCT05722561** · PHASE2 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 302 (estimated)

## Conditions studied

- Opioid Use Disorder
- Cigarette Smoking

## Interventions

- **BEHAVIORAL:** Telehealth Motivational Counseling
- **DRUG:** Nicotine Replacement Product
- **DEVICE:** National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).

## Key facts

- **NCT ID:** NCT05722561
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-08
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 302 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05722561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05722561, "E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05722561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*